Literature DB >> 9069490

Down's syndrome and Parkinson's disease.

A Hestnes, S E Daniel, A J Lees, A Brun.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9069490      PMCID： PMC1064164          DOI： 10.1136/jnnp.62.3.289

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  8 in total

1.  The substantia nigra and ventral tegmental area in Alzheimer's disease and Down's syndrome.

Authors:  W R Gibb; C Q Mountjoy; D M Mann; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

Review 2.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

3.  A pathological study of the association between Lewy body disease and Alzheimer's disease.

Authors:  W R Gibb; C Q Mountjoy; D M Mann; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

4.  Levodopa-responsive parkinsonism in a patient with Down's syndrome.

Authors:  C Singer; J Sanchez-Ramos; W J Weiner
Journal:  Eur Neurol       Date:  1990       Impact factor: 1.710

5.  A case of Down's syndrome with diffuse Lewy body disease and Alzheimer's disease.

Authors:  S Bodhireddy; D W Dickson; L Mattiace; K M Weidenheim
Journal:  Neurology       Date:  1994-01       Impact factor: 9.910

6.  Detection of Lewy bodies in Trisomy 21 (Down's syndrome).

Authors:  R Raghavan; C Khin-Nu; A Brown; D Irving; P G Ince; K Day; S P Tyrer; R H Perry
Journal:  Can J Neurol Sci       Date:  1993-02       Impact factor: 2.104

7.  Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations.

Authors:  F Boller; T Mizutani; U Roessmann; P Gambetti
Journal:  Ann Neurol       Date:  1980-04       Impact factor: 10.422

8.  Extrapyramidal features in advanced Down's syndrome: clinical evaluation and family history.

Authors:  P Vieregge; G Ziemens; M Freudenberg; A Piosinski; A Muysers; B Schulze
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-01       Impact factor: 10.154
  8 in total
  2 in total

1.  DYRK1A promotes dopaminergic neuron survival in the developing brain and in a mouse model of Parkinson's disease.

Authors:  M J Barallobre; C Perier; J Bové; A Laguna; J M Delabar; M Vila; M L Arbonés
Journal:  Cell Death Dis       Date:  2014-06-12       Impact factor: 8.469

2.  Atypical Localization and Dissociation between Glucose Uptake and Amyloid Deposition in Cognitively Normal APOE*E4 Homozygotic Elders Compared with Patients with Late-Onset Alzheimer's Disease.

Authors:  José V Pardo; Joel T Lee
Journal:  eNeuro       Date:  2018-02-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.